Market revenue in 2023 | USD 104.6 million |
Market revenue in 2030 | USD 251.8 million |
Growth rate | 13.4% (CAGR from 2023 to 2030) |
Largest segment | Outsourcing |
Fastest growing segment | Outsourcing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | In-House, Outsourcing |
Key market players worldwide | Steris PLC, Sotera Health Co Ordinary Shares, Sartorius AG, Solvias, SGS AG, Labcorp Holdings Inc, Pace Analytical Services, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc, Rapid Micro Biosystems Inc Class A, Almac Group, Pacific BioLabs, Inc., Boston Analytical, Labor LS |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical sterility testing market will help companies and investors design strategic landscapes.
Outsourcing was the largest segment with a revenue share of 59.46% in 2023. Horizon Databook has segmented the China pharmaceutical sterility testing market based on in-house, outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.
China is one of the most technologically advanced countries, which significantly contributes to the healthcare industry of the region. In addition, the rising geriatric population and the presence of a large fraction of the population belonging to the middle-income group increases the demand for innovative & cost-effective medical equipment, which is expected to attract major medical device companies.
Moreover, China has become an attractive destination for outsourcing clinical trials due to its large population, diverse patient demographics, and cost-effectiveness. As a result, domestic and international pharmaceutical companies outsource their clinical trials to Contract Research Organizations (CROs) in China, driving the demand for sterility testing services.
Horizon Databook provides a detailed overview of country-level data and insights on the China pharmaceutical sterility testing market , including forecasts for subscribers. This country databook contains high-level insights into China pharmaceutical sterility testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account